Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Appili Therapeutics Inc

APLIF
Current price
0.028 USD 0 USD (0.00%)
Last closed 0.04 CAD
ISIN CA03783R1073
Sector Healthcare
Industry Biotechnology
Exchange TO
Capitalization 4 248 280 CAD
Yield for 12 month +14.29 %
1Y
3Y
5Y
10Y
15Y
APLIF
21.11.2021 - 28.11.2021

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada. Address: #21-1344 Summer Street, Halifax, NS, Canada, B3H 0A8

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.21 CAD

P/E ratio

Dividend Yield

Current Year

+828 181 CAD

Last Year

+334 489 CAD

Current Quarter

Last Quarter

+11 708 CAD

Current Year

+814 506 CAD

Last Year

+328 218 CAD

Current Quarter

-3 368 CAD

Last Quarter

+8 486 CAD

Key Figures APLIF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -8 598 455 CAD
Operating Margin TTM -1039.88 %
PE Ratio
Return On Assets TTM -244.22 %
PEG Ratio
Return On Equity TTM -938.72 %
Wall Street Target Price 0.21 CAD
Revenue TTM 828 181 CAD
Book Value -0.1 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -96.5 %
Dividend Yield
Gross Profit TTM 1 391 985 CAD
Earnings per share -0.03 CAD
Diluted Eps TTM -0.03 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics APLIF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History APLIF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation APLIF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.3776
Enterprise Value Revenue 16.9144
Price Sales TTM 5.1297
Enterprise Value EBITDA -3.6137
Price Book MRQ 1.3981

Financials APLIF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators APLIF

For 52 weeks

0.025 CAD 0.06 CAD
50 Day MA 0.033 CAD
Shares Short Prior Month 3 563
200 Day MA 0.035 CAD
Short Ratio 0.03
Shares Short 11 123
Short Percent 0.56 %